Compare Cassava Sciences Inc (FLNA) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs State Street Technology Select Sector SPDR ETF — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while State Street Technology Select Sector SPDR ETF trades at $177.5. The key difference: State Street Technology Select Sector SPDR ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | XLK | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.64 | $198.21 |
52-Week Low | $1.09 | $127.49 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
XLK trades at $178.19, down 2.96% over the past 24 hours amid a bearish technical signal. The ETF remains the top-performing sector SPDR in 2026 with 33% year-to-date gains (ETF Trends, 2026-07-02). Technical indicators show resistance at $184 and support at $176, with neutral momentum oscillators suggesting consolidation. Recent news highlights strong technology sector earnings expectations and institutional inflows.
Outlook remains positive given sector leadership and earnings growth catalysts, though concentration risk and valuation concerns pose headwinds. The ETF's lower expense ratio and focused tech exposure offer strategic advantages, but investors face volatility from Fed policy and macroeconomic shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
